Related Experiment Video
Updated: Jun 2, 2026

21:08
Engineering Cell-permeable Protein
Published on: December 28, 2009
Strain engineering for improved expression of recombinant proteins in bacteria
Tomohiro Makino1, Georgios Skretas, George Georgiou
1Department of Chemical Engineering, The University of Texas at Austin, 78712, USA.
Microbial Cell Factories
|May 17, 2011
Summary
Genome-scale engineering of Escherichia coli (E. coli) offers new methods to optimize recombinant protein production. This approach moves beyond trial-and-error, enabling efficient expression of challenging proteins.
Area of Science:
- Biotechnology
- Molecular Biology
- Microbial Engineering
Background:
- Escherichia coli (E. coli) is a primary host for producing non-glycosylated proteins for research and applications.
- Traditional recombinant protein expression optimization in E. coli often involves empirical, trial-and-error methods.
- Existing methods require adjusting parameters like expression vectors, media, temperature, and chaperone co-expression.
Purpose of the Study:
- To review recent advancements in genome-scale engineering of E. coli for enhanced recombinant protein expression.
- To highlight methodologies that facilitate the development of optimized E. coli expression strains.
- To discuss strain engineering strategies for producing difficult-to-express proteins, including membrane proteins.
Main Methods:
- Genome-scale engineering of E. coli.
- Development of novel E. coli expression strains.
- Application of metabolic engineering principles to protein expression.
- Systematic optimization of expression parameters.
Main Results:
- New genome-scale engineering approaches enable rational design of E. coli expression strains.
- These methods allow for the creation of strains optimized for high-yield recombinant protein production.
- The engineered strains are particularly useful for expressing challenging proteins, such as heterologous membrane proteins.
Conclusions:
- Genome-scale engineering represents a significant advancement over traditional methods for optimizing E. coli protein expression.
- This approach allows for the systematic generation of tailored E. coli strains for specific protein production needs.
- The reviewed methodologies provide a powerful toolkit for overcoming challenges in expressing difficult proteins.
More Related Videos
Related Concept Videos
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

